{"id":39215,"date":"2026-02-12T11:42:32","date_gmt":"2026-02-12T11:42:32","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/immuno-oncology-assays-market-mordor\/"},"modified":"2026-10-23T20:25:32","modified_gmt":"2026-10-23T11:25:32","slug":"immuno-oncology-assays-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/immuno-oncology-assays-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uba74\uc5ed\ud56d\uc554 \ubd84\uc11d \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/immuno-oncology-assays-market_1666703563941_Screenshot_2022-10-25_184224.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/immuno-oncology-assays-market-size-image-1770820451373.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud604\ud669<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc804 \uc138\uacc4 \uc554 \ubc1c\uc0dd\ub960\uc758 \uc9c0\uc18d\uc801\uc778 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c \ucc44\ud0dd \ud655\ub300<\/li>\n<li class=\"toc-level-3\">4.2.3 \ub3d9\ubc18\uc9c4\ub2e8(Dx) \ubd84\uc11d\ubc95(PD-1\/PD-L1, TMB)\uc758 \uaddc\uc81c \uc2b9\uc778<\/li>\n<li class=\"toc-level-3\">4.2.4 \uc81c\uc57d-\uc9c4\ub2e8(Dx) \uacf5\ub3d9 \uac1c\ubc1c \ud30c\ud2b8\ub108\uc2ed\uc744 \ud1b5\ud55c \uac80\uc0ac \uba54\ub274 \uac00\uc18d\ud654<\/li>\n<li class=\"toc-level-3\">4.2.5 AI \uae30\ubc18 \ub2e4\uc911 \uacf5\uac04 \ud504\ub85c\ud30c\uc77c\ub9c1\uc744 \ud1b5\ud55c \ubc14\uc774\uc624\ub9c8\ucee4 \ubc1c\uad74 \ucd09\uc9c4<\/li>\n<li class=\"toc-level-3\">4.2.6 \uc9c0\uc5ed\uc0ac\ud68c \uc885\uc591\ud559 \ubd84\uc57c\uc758 \ubd84\uc0b0\ud615 \uc561\uccb4 \uc0dd\uac80 \uac80\uc0ac<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ub192\uc740 \ubd84\uc11d \ube44\uc6a9 \ubc0f \ubcf5\uc7a1\ud55c \uc0c1\ud658 \uacbd\ub85c<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc5c4\uaca9\ud55c \ub2e4\uc911 \uad00\ud560\uad8c \uaddc\uc81c \uc720\ud6a8\uc131 \uac80\uc0ac \uc694\uad6c\uc0ac\ud56d<\/li>\n<li class=\"toc-level-3\">4.3.3 \uc798 \uc8fc\uc11d \ucc98\ub9ac\ub41c \uc77c\uce58\ud558\ub294 \uc885\uc591\/\uc815\uc0c1 \ubc14\uc774\uc624\ubc45\ud06c\uc758 \ubd80\uc871<\/li>\n<li class=\"toc-level-3\">4.3.4 \ub2e4\uc911 \ubd84\uc11d \ud504\ub85c\ud1a0\ucf5c\uc758 \uae00\ub85c\ubc8c \ud45c\uc900\ud654 \ubd80\uc871<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uac00\uce58 \/ \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1\uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58-USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc81c\ud488\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc2dc\uc57d \ubc0f \ud56d\uccb4<\/li>\n<li class=\"toc-level-3\">5.1.2 \uae30\uae30<\/li>\n<li class=\"toc-level-3\">5.1.3 \uc18c\ud504\ud2b8\uc6e8\uc5b4 \ubc0f \ubd84\uc11d<\/li>\n<li class=\"toc-level-3\">5.1.4 \uc18c\ubaa8\ud488 \ubc0f \uc561\uc138\uc11c\ub9ac<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uae30\uc220\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uba74\uc5ed\ubd84\uc11d (ELISA, CLIA)<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc911\ud569\ud6a8\uc18c \uc5f0\uc1c4 \ubc18\uc751 (PCR\/qPCR\/ddPCR)<\/li>\n<li class=\"toc-level-3\">5.2.3 \ucc28\uc138\ub300 \uc5fc\uae30\uc11c\uc5f4 \ubd84\uc11d (NGS)<\/li>\n<li class=\"toc-level-3\">5.2.4 \uc720\uc138\ud3ec \ubd84\uc11d<\/li>\n<li class=\"toc-level-3\">5.2.5 \ub2e4\uc911 \uacf5\uac04 \ud504\ub85c\ud30c\uc77c\ub9c1 (mIF, IMC, DSP)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \ubd84\uc11d \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ub3d9\ubc18 \uc9c4\ub2e8 (CDx) \ubd84\uc11d<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc790\uccb4 \uac1c\ubc1c \uac80\uc0ac (LDTs)<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc5f0\uad6c\uc6a9 (RUO) \ud328\ub110<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uc801\uc751\uc99d\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ud3d0\uc554<\/li>\n<li class=\"toc-level-3\">5.4.2 \ub300\uc7a5\uc554<\/li>\n<li class=\"toc-level-3\">5.4.3 \ud751\uc0c9\uc885<\/li>\n<li class=\"toc-level-3\">5.4.4 \uc720\ubc29\uc554<\/li>\n<li class=\"toc-level-3\">5.4.5 \uae30\ud0c0 \uc554<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc0d8\ud50c \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \uc870\uc9c1 \uc0dd\uac80<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc561\uccb4 \uc0dd\uac80 (\ud608\uc561, \ud608\uc7a5, cfDNA)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.6 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.6.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.6.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.6.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.6.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.6.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.6.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.6.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.6.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.6.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.6.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.6.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.6.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.6.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.6.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.6.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.6.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.6.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.6.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.6.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.6.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.6.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.6.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 {(\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc81c\ud488 &amp; \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)}\n<ul>\n<li class=\"toc-level-3\">6.3.1 Agilent Technologies<\/li>\n<li class=\"toc-level-3\">6.3.2 Thermo Fisher Scientific<\/li>\n<li class=\"toc-level-3\">6.3.3 Illumina<\/li>\n<li class=\"toc-level-3\">6.3.4 PerkinElmer<\/li>\n<li class=\"toc-level-3\">6.3.5 Roche<\/li>\n<li class=\"toc-level-3\">6.3.6 Merck KGaA<\/li>\n<li class=\"toc-level-3\">6.3.7 HTG Molecular Diagnostics<\/li>\n<li class=\"toc-level-3\">6.3.8 Crown Bioscience<\/li>\n<li class=\"toc-level-3\">6.3.9 InSphero<\/li>\n<li class=\"toc-level-3\">6.3.10 Qiagen<\/li>\n<li class=\"toc-level-3\">6.3.11 Bio-Rad Laboratories<\/li>\n<li class=\"toc-level-3\">6.3.12 NanoString Technologies<\/li>\n<li class=\"toc-level-3\">6.3.13 ArcherDx (Invitae)<\/li>\n<li class=\"toc-level-3\">6.3.14 Adaptive Biotechnologies<\/li>\n<li class=\"toc-level-3\">6.3.15 Sysmex<\/li>\n<li class=\"toc-level-3\">6.3.16 Oxford Nanopore Tech.<\/li>\n<li class=\"toc-level-3\">6.3.17 Guardant Health<\/li>\n<li class=\"toc-level-3\">6.3.18 NeoGenomics<\/li>\n<li class=\"toc-level-3\">6.3.19 Foundation Medicine<\/li>\n<li class=\"toc-level-3\">6.3.20 Danaher (Leica-Cytiva)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc11d \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc608\uce21 (2026-2031)<\/p>\n<p>\uc2dc\uc7a5 \uac1c\uc694<\/p>\n<p>\uae00\ub85c\ubc8c \uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc11d(Immuno-Oncology Assays) \uc2dc\uc7a5\uc740 2025\ub144 60.5\uc5b5 \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 118.7\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc608\uce21 \uae30\uac04(2026-2031) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 11.88%\ub97c \uae30\ub85d\ud560 \uc804\ub9dd\uc785\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \uc804 \uc138\uacc4\uc801\uc778 \uc554 \ubc1c\ubcd1\ub960 \uc99d\uac00, \ub3d9\ubc18 \uc9c4\ub2e8(Companion Diagnostics, CDx)\uc5d0 \ub300\ud55c \uafb8\uc900\ud55c \uaddc\uc81c \uc9c0\uc6d0, \uadf8\ub9ac\uace0 \uacf5\uac04 \uc0dd\ubb3c\ud559(Spatial Biology) \ud50c\ub7ab\ud3fc\uc758 \ucc44\ud0dd \uac00\uc18d\ud654\uc5d0 \ud798\uc785\uc5b4 \uc815\uad50\ud55c \uba74\uc5ed \ud504\ub85c\ud30c\uc77c\ub9c1 \ud14c\uc2a4\ud2b8\uc5d0 \ub300\ud55c \uc218\uc694\uac00 \uc99d\uac00\ud558\uace0 \uc788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \uc81c\uc57d-\uc9c4\ub2e8 \uae30\uc5c5 \uac04\uc758 \ud30c\ud2b8\ub108\uc2ed\uc740 \ud14c\uc2a4\ud2b8 \uac80\uc99d \uae30\uac04\uc744 \ub2e8\ucd95\ud558\uace0 \uba54\ub274\ub97c \ud655\uc7a5\ud558\uba70, \uc778\uacf5\uc9c0\ub2a5(AI) \ud1b5\ud569\uc740 \ubd84\uc11d\uc758 \uc815\ud655\ub3c4\uc640 \ucc98\ub9ac\ub7c9\uc744 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubd81\ubbf8 \uc9c0\uc5ed\uc774 \uc720\ub9ac\ud55c \uc0c1\ud658 \uc815\ucc45\uc73c\ub85c \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud558\uace0 \uc788\uc9c0\ub9cc, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc758\ub8cc \uc778\ud504\ub77c \uc131\uc219 \ubc0f \uc784\uc0c1 \uc2dc\ud5d8 \ud65c\ub3d9 \uc99d\uac00\ub85c \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\uc744 \ubcf4\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uacbd\uc7c1 \uc804\ub7b5\uc740 \ub2e4\uc911 \uc624\ubbf9\uc2a4(multi-omics) \ud1b5\ud569 \ubc0f \uc2e4\uc81c \uc99d\uac70(real-world evidence) \uc0dd\uc131\uc5d0 \uc810\uc810 \ub354 \uc911\uc810\uc744 \ub450\uc5b4, \ubbfc\ucca9\ud55c \uae30\uc220 \uc81c\uacf5\uc5c5\uccb4\ub4e4\uc774 \uc9c0\uc5ed \uc554 \uce58\ub8cc \ud658\uacbd\uc5d0\uc11c \uc0c1\ub2f9\ud55c \uc810\uc720\uc728\uc744 \ud655\ubcf4\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \ubcf4\uace0\uc11c \uc694\uc57d<\/p>\n<p>*   \uc81c\ud488\ubcc4: 2025\ub144 \uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc11d \uc2dc\uc7a5\uc5d0\uc11c \uc2dc\uc57d \ubc0f \ud56d\uccb4\uac00 39.65%\uc758 \uc810\uc720\uc728\ub85c \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc18c\ud504\ud2b8\uc6e8\uc5b4 \ubc0f \ubd84\uc11d \ubd80\ubb38\uc740 2031\ub144\uae4c\uc9c0 12.41%\uc758 \uac00\uc7a5 \ub192\uc740 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uae30\uc220\ubcc4: 2025\ub144 \ucc28\uc138\ub300 \uc5fc\uae30\uc11c\uc5f4 \ubd84\uc11d(Next-Generation Sequencing, NGS)\uc774 37.10%\uc758 \ub9e4\ucd9c \uc810\uc720\uc728\uc744 \uae30\ub85d\ud558\uba70 \uc2dc\uc7a5\uc744 \uc8fc\ub3c4\ud588\uc2b5\ub2c8\ub2e4. \ub2e4\uc911 \uacf5\uac04 \ud504\ub85c\ud30c\uc77c\ub9c1(Multiplex Spatial Profiling)\uc740 2031\ub144\uae4c\uc9c0 12.48%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \ud655\uc7a5\ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \ubd84\uc11d \uc720\ud615\ubcc4: 2025\ub144 \uc5f0\uad6c\uc2e4 \uac1c\ubc1c \ud14c\uc2a4\ud2b8(Laboratory-Developed Tests, LDTs)\uac00 \uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc11d \uc2dc\uc7a5\uc758 50.55%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \ub3d9\ubc18 \uc9c4\ub2e8(Companion Diagnostics, CDx)\uc740 2031\ub144\uae4c\uc9c0 12.44%\uc758 \uac00\uc7a5 \ub192\uc740 \uc608\uce21 CAGR\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uc801\uc751\uc99d\ubcc4: 2025\ub144 \ud3d0\uc554\uc774 \uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc11d \uc2dc\uc7a5\uc758 31.65%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc720\ubc29\uc554\uc740 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 12.62%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc0d8\ud50c \uc720\ud615\ubcc4: 2025\ub144 \uc870\uc9c1 \uc0dd\uac80(Tissue Biopsy)\uc774 \uae00\ub85c\ubc8c \uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc11d \uc2dc\uc7a5\uc758 52.35%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc561\uccb4 \uc0dd\uac80(Liquid Biopsy)\uc740 2031\ub144\uae4c\uc9c0 12.46%\uc758 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: 2025\ub144 \ubd81\ubbf8\uac00 \uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc11d \uc2dc\uc7a5\uc758 41.90%\ub97c \uc810\uc720\ud588\uc2b5\ub2c8\ub2e4. \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 2031\ub144\uae4c\uc9c0 12.55%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc9c0\uc5ed\uc774 \ub420 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>\uae00\ub85c\ubc8c \uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc11d \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825<\/p>\n<p>1. \uc2dc\uc7a5 \ub3d9\uc778<\/p>\n<p>*   \uc804 \uc138\uacc4 \uc554 \ubc1c\ubcd1\ub960\uc758 \uc9c0\uc18d\uc801\uc778 \uc99d\uac00: \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uc554 \ubc1c\ubcd1\ub960\uc774 \uafb8\uc900\ud788 \uc99d\uac00\ud558\uba74\uc11c \uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc11d\uc5d0 \ub300\ud55c \uc218\uc694\uac00 \uc7a5\uae30\uc801\uc73c\ub85c \ucd09\uc9c4\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \ub4f1 \uace0\ub839\ud654 \uc778\uad6c\uac00 \ub9ce\uc740 \uc9c0\uc5ed\uc5d0\uc11c \ud2b9\ud788 \ub450\ub4dc\ub7ec\uc9d1\ub2c8\ub2e4.<br \/>\n*   \uba74\uc5ed\uad00\ubb38 \uc5b5\uc81c\uc81c \ucc44\ud0dd \ud655\ub300: \uba74\uc5ed\uad00\ubb38 \uc5b5\uc81c\uc81c\ub294 \uce58\ub8cc \ud658\uacbd\uc744 \ubcc0\ud654\uc2dc\ud0a4\uace0 \uc788\uc73c\uba70, PD-L1 \uc0c1\ud0dc, \uc885\uc591 \ubcc0\uc774 \ubd80\ub2f4(Tumor Mutational Burden, TMB), \ubbf8\uc138\uc704\uc131 \ubd88\uc548\uc815\uc131(Microsatellite Instability, MSI)\uc744 \uce21\uc815\ud558\ub294 \ub3d9\ubc18 \ud14c\uc2a4\ud2b8\uc758 \uad11\ubc94\uc704\ud55c \ubc30\ud3ec\ub97c \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2025\ub144 FDA\uc758 \uc5ec\ub7ec \uc2b9\uc778(\uc608: \uc2dd\ub3c4 \ud3b8\ud3c9 \uc138\ud3ec\uc554\uc5d0 \ub300\ud55c \ud2f0\uc2ac\ub810\ub9ac\uc8fc\ub9d9+\ud654\ud559\uc694\ubc95, HER2 \uc591\uc131 \uc704\uc554\uc5d0 \ub300\ud55c \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9-\ud2b8\ub77c\uc2a4\ud22c\uc8fc\ub9d9)\uc740 \uac15\ub825\ud55c \uc608\uce21 \ubd84\uc11d\uc758 \ud544\uc694\uc131\uc744 \uac15\uc870\ud569\ub2c8\ub2e4. \uacf5\uac04 \uc624\ubbf9\uc2a4 \ud50c\ub7ab\ud3fc\uc740 \uc885\uc591 \ubbf8\uc138 \ud658\uacbd\uc758 \ub2e4\ucc28\uc6d0 \ubd84\uc11d\uc744 \uac00\ub2a5\ud558\uac8c \ud558\uc5ec \ubd84\uc11d \ud2b9\uc774\uc131\uc744 \ub192\uc785\ub2c8\ub2e4.<br \/>\n*   AI \uae30\ubc18 \ub2e4\uc911 \uacf5\uac04 \ud504\ub85c\ud30c\uc77c\ub9c1\uc744 \ud1b5\ud55c \ubc14\uc774\uc624\ub9c8\ucee4 \ubc1c\uad74 \ucd09\uc9c4: AI\uc640 \uacf5\uac04 \uc0dd\ubb3c\ud559 \uae30\uc220\uc758 \uacb0\ud569\uc740 \uae30\uc874 \uc811\uadfc \ubc29\uc2dd\uc73c\ub85c\ub294 \uc228\uaca8\uc838 \uc788\ub358 \uc138\ud3ec \uc0c1\ud638\uc791\uc6a9\uc744 \ubc1d\ud600\ub0c5\ub2c8\ub2e4. Garvan Institute\uc758 AAnet \ub3c4\uad6c\ub294 5\uac00\uc9c0 \uc885\uc591 \uc0c1\uc8fc \uc138\ud3ec \uc720\ud615\uc744 \uad6c\ubcc4\ud558\uc5ec \uce58\ub8cc \uc804\ub7b5\uc744 \uc218\ub9bd\ud558\ub294 \ub370 \uae30\uc5ec\ud569\ub2c8\ub2e4. Hyperion XTi Imaging Mass Cytometer\uc640 \uac19\uc740 \uc0c1\uc5c5\uc6a9 \uc2dc\uc2a4\ud15c\uc740 \uc790\uac00 \ud615\uad11 \ub178\uc774\uc988 \uc5c6\uc774 40\uac1c \uc774\uc0c1\uc758 \ub9c8\ucee4\ub97c \ub3d9\uc2dc\uc5d0 \uc2dc\uac01\ud654\ud558\uc5ec \ubc14\uc774\uc624\ub9c8\ucee4 \ud30c\uc774\ud504\ub77c\uc778\uc744 \uc2ec\ud654\uc2dc\ud0b5\ub2c8\ub2e4.<br \/>\n*   \ub3d9\ubc18 \uc9c4\ub2e8(CDx) \ubd84\uc11d\uc758 \uaddc\uc81c \uc2b9\uc778: therascreen KRAS RGQ PCR \ud0a4\ud2b8(KRAS G12C \ubcc0\uc774) \ubc0f VENTANA MET (SP44) \ubd84\uc11d(c-Met \ubc1c\ud604)\uacfc \uac19\uc740 \ucd5c\uadfc FDA \uc2b9\uc778\uc740 \ub2e4\uc911 \ub9e4\uac1c\ubcc0\uc218 \uc9c4\ub2e8\uc73c\ub85c\uc758 \uaddc\uc81c \ubcc0\ud654\ub97c \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. Ventana TROP2 \ubd84\uc11d\uc5d0 \ub300\ud55c \ud601\uc2e0 \uc758\ub8cc\uae30\uae30 \uc9c0\uc815\uc740 AI \uae30\ubc18 \ubcd1\ub9ac\ud559\uc774 \uc2b9\uc778 \uc8fc\uae30\ub97c \ub2e8\ucd95\ud558\ub294 \ubc29\ubc95\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \ud655\uc7a5\ub41c \uba54\ub274\ub294 \uc9c4\ud654\ud558\ub294 \uce58\ub8cc \uc54c\uace0\ub9ac\uc998\uc5d0 \ub9de\ub294 \uac80\uc99d\ub41c \ub3c4\uad6c\ub97c \uc784\uc0c1\uc758\uc5d0\uac8c \uc81c\uacf5\ud558\uc5ec \uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc11d \uc2dc\uc7a5\uc744 \uac15\ud654\ud569\ub2c8\ub2e4.<br \/>\n*   \uc81c\uc57d-\uc9c4\ub2e8 \uacf5\ub3d9 \uac1c\ubc1c \ud30c\ud2b8\ub108\uc2ed\uc744 \ud1b5\ud55c \ud14c\uc2a4\ud2b8 \uba54\ub274 \uac00\uc18d\ud654: \uc57d\ubb3c \uac1c\ubc1c\uc790\uc640 \ubd84\uc11d \ud68c\uc0ac \uac04\uc758 \ud611\ub825\uc740 R&#038;D \uc77c\uc815\uc744 \ub2e8\ucd95\ud569\ub2c8\ub2e4. GeneCentric\uacfc Labcorp\ub294 RNA \uc720\uc804\uc790 \uc2dc\uadf8\ub2c8\ucc98\ub97c \uacf5\ub3d9 \uac1c\ubc1c\ud558\uace0, Guardant Health\uc640 ConcertAI\ub294 550\ub9cc \uac74\uc758 \uc2e4\uc81c \uae30\ub85d\uc744 \ud6c4\uc131\uc720\uc804\uccb4 \ud504\ub85c\ud30c\uc77c\uacfc \ud1b5\ud569\ud558\uc5ec \uc99d\uac70 \uc0dd\uc131\uc744 \uac1c\uc120\ud569\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc81c\ud734\ub294 \uc0c8\ub85c\uc6b4 \ubc14\uc774\uc624\ub9c8\ucee4\ub97c \uc2dc\uc7a5\uc5d0 \ucd9c\uc2dc\ud558\ub294 \ube44\uc6a9\uacfc \ubcf5\uc7a1\uc131\uc744 \uc904\uc5ec \uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc11d \uc2dc\uc7a5\uc758 \ubc1c\uc790\ucde8\ub97c \ud655\uc7a5\ud569\ub2c8\ub2e4.<\/p>\n<p>2. \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778<\/p>\n<p>*   \ub192\uc740 \ubd84\uc11d \ube44\uc6a9 \ubc0f \ubcf5\uc7a1\ud55c \uc0c1\ud658 \uacbd\ub85c: NGS\uc5d0 \ub300\ud55c \uba54\ub514\ucf00\uc5b4 \uccad\uad6c \uac70\ubd80\uc728\uc774 2025\ub144 16.8%\uc5d0\uc11c 27.4%\ub85c \uae09\uc99d\ud55c \uac83\uc740 \ubbf8\uad6d \uc9c0\ubd88\uc790\ub4e4\uc758 \uc2ec\uc0ac\uac00 \uac15\ud654\ub418\uace0 \uc788\uc74c\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \uc644\uc804\ud55c \uacf5\uac04 \ud504\ub85c\ud30c\uc77c\ub9c1 \uc124\ube44\uc5d0 50\ub9cc \ub2ec\ub7ec\ub97c \ucd08\uacfc\ud558\ub294 \uc790\ubcf8 \ud22c\uc790\ub294 \uc9c0\uc5ed \uc0ac\ud68c \ud658\uacbd\uc5d0\uc11c\uc758 \ud655\uc0b0\uc744 \uc81c\ud55c\ud569\ub2c8\ub2e4. \uc720\ub7fd\uc758 \ubcf4\uac74 \uae30\uc220 \ud3c9\uac00(Health Technology Assessments, HTA)\ub294 \ucd9c\uc2dc \uc77c\uc815\uc744 12-18\uac1c\uc6d4 \uc5f0\uc7a5\ud558\uc5ec \uc18c\uaddc\ubaa8 \uac1c\ubc1c\uc5c5\uccb4\uc758 \uc7ac\uc815\uc801 \uc704\ud5d8\uc744 \uc99d\uac00\uc2dc\ud0b5\ub2c8\ub2e4.<br \/>\n*   \uc5c4\uaca9\ud55c \ub2e4\uc911 \uad00\ud560\uad8c \uaddc\uc81c \uac80\uc99d \uc694\uad6c\uc0ac\ud56d: FDA, EMA \ubc0f \uae30\ud0c0 \uaddc\uc81c \uae30\uad00 \uac04\uc758 \uc0c1\uc774\ud55c \uae30\uc900\uc740 \uac80\uc99d \uc8fc\uae30\ub97c \uae38\uac8c \ub9cc\ub4ed\ub2c8\ub2e4. PD-L1 \ud14c\uc2a4\ud2b8\uc758 20%\ub97c \ucd08\uacfc\ud558\ub294 \uc2e4\ud5d8\uc2e4 \uac04 \ubcc0\ub3d9 \uacc4\uc218\ub294 \uc7ac\ud604\uc131 \ubb38\uc81c\ub97c \uac15\uc870\ud569\ub2c8\ub2e4. CIMAC-CIDC\uc640 \uac19\uc740 \uc870\uc9c1\uc740 \uc870\ud654\ub97c \ubaa8\uc0c9\ud558\uace0 \uc788\uc9c0\ub9cc, \ud604\uc9c0\ud654 \uc694\uad6c\uc0ac\ud56d\uc740 \uc6b4\uc601 \uac04\uc811\ube44\ub97c \uc99d\uac00\uc2dc\ud0b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc7a5\uc560\ubb3c\uc740 \uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc11d \uc2dc\uc7a5\uc758 \uac15\ub825\ud55c \uc131\uc7a5 \uada4\ub3c4\ub97c \uc5b5\uc81c\ud569\ub2c8\ub2e4.<br \/>\n*   \uc798 \uc8fc\uc11d\uc774 \ub2ec\ub9b0 \uc77c\uce58 \uc885\uc591\/\uc815\uc0c1 \ubc14\uc774\uc624\ubc45\ud06c\uc758 \ubd80\uc871: \uc5f0\uad6c \uc9d1\uc57d\uc801\uc778 \uc9c0\uc5ed\uc5d0\uc11c \ud2b9\ud788 \uc601\ud5a5\uc744 \ubbf8\uce58\ub294 \ubc14\uc774\uc624\ubc45\ud06c\uc758 \ubd80\uc871\uc740 \uc0c8\ub85c\uc6b4 \ubc14\uc774\uc624\ub9c8\ucee4 \ubc1c\uad74 \ubc0f \ubd84\uc11d \uac1c\ubc1c\uc744 \ubc29\ud574\ud569\ub2c8\ub2e4.<br \/>\n*   \ub2e4\uc911 \ubd84\uc11d \ud504\ub85c\ud1a0\ucf5c\uc758 \uae00\ub85c\ubc8c \ud45c\uc900\ud654 \ubd80\uc871: \ud2b9\ud788 \uc2e0\ud765 \uc2dc\uc7a5\uc5d0\uc11c \ub450\ub4dc\ub7ec\uc9c0\ub294 \ud45c\uc900\ud654 \ubd80\uc871\uc740 \ubd84\uc11d \uacb0\uacfc\uc758 \ube44\uad50 \uac00\ub2a5\uc131\uacfc \uc0c1\ud638 \uc6b4\uc6a9\uc131\uc744 \uc800\ud574\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>*   \uc81c\ud488\ubcc4: \uc2dc\uc57d \ubc0f \ud56d\uccb4\ub294 \uba74\uc5ed \ud14c\uc2a4\ud2b8 \uc6cc\ud06c\ud50c\ub85c\uc6b0\uc758 \uc18c\ubaa8\ud488 \uc911\uc2ec \ud2b9\uc131\uc744 \ubc18\uc601\ud558\uc5ec 2025\ub144 \uc2dc\uc7a5\uc758 39.65%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \ubcd1\uc6d0 \ubc0f \ucc38\uc870 \uc2e4\ud5d8\uc2e4\uc740 SITC(Society for Immunotherapy of Cancer)\uac00 \uc2b9\uc778\ud55c \ubc14\uc774\uc624\ub9c8\ucee4 \uc694\uad6c\uc0ac\ud56d\uc744 \ucda9\uc871\ud558\uae30 \uc704\ud574 \uac80\uc99d\ub41c \ud56d\uccb4 \ud328\ub110\uc744 \uc0ac\uc6a9\ud569\ub2c8\ub2e4. \uae30\uae30\ub294 40\uac1c \uc774\uc0c1\uc758 \ub9c8\ucee4\ub97c \uac10\uc9c0\ud560 \uc218 \uc788\ub294 \uc774\ubbf8\uc9d5 \uc9c8\ub7c9 \uc138\ud3ec \ubd84\uc11d \ud50c\ub7ab\ud3fc\uc73c\ub85c \uc5c5\uadf8\ub808\uc774\ub4dc\ud558\ub294 \uc2e4\ud5d8\uc2e4\uc758 \uafb8\uc900\ud55c \uc218\uc694\ub97c \ub204\ub9ac\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc18c\ud504\ud2b8\uc6e8\uc5b4 \ubc0f \ubd84\uc11d\uc740 AI \ubaa8\ub4c8\uacfc \ud074\ub77c\uc6b0\ub4dc \uae30\ubc18 \ub370\uc774\ud130 \uacf5\uc720\uc758 \uc774\uc810\uc744 \ud1b5\ud574 2031\ub144\uae4c\uc9c0 12.41%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uae30\uc220\ubcc4: \ucc28\uc138\ub300 \uc5fc\uae30\uc11c\uc5f4 \ubd84\uc11d(NGS)\uc740 \uad11\ubc94\uc704\ud55c \ub3cc\uc5f0\ubcc0\uc774 \uc2a4\uce94\uc5d0 \ud544\uc218\uc801\uc774\uba70 2025\ub144 \uc2dc\uc7a5\uc758 37.10%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uace0\uc2ec\ub3c4 \ud328\ub110 \uc2dc\ud000\uc2f1\uc740 \uc885\uc591 \ubcc0\uc774 \ubd80\ub2f4 \uacc4\uc0b0\uc744 \uc9c0\uc6d0\ud558\uc5ec \uba74\uc5ed\uad00\ubb38 \uc5b5\uc81c\uc81c \uc0ac\uc6a9\uc744 \uc9c1\uc811\uc801\uc73c\ub85c \uc548\ub0b4\ud569\ub2c8\ub2e4. \ub2e4\uc911 \uacf5\uac04 \ud504\ub85c\ud30c\uc77c\ub9c1\uc740 12.48%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc190\uc0c1\ub418\uc9c0 \uc54a\uc740 \uc870\uc9c1 \ub0b4\uc5d0\uc11c \ub2e8\uc77c \uc138\ud3ec \ud574\uc0c1\ub3c4\ub85c \ub2e8\ubc31\uc9c8 \ubc0f RNA \ub9c8\ucee4\ub97c \ub9e4\ud551\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ubd84\uc11d \uc720\ud615\ubcc4: \uc5f0\uad6c\uc2e4 \uac1c\ubc1c \ud14c\uc2a4\ud2b8(LDTs)\ub294 \uc720\uc5f0\ud55c \ubd84\uc11d \uc124\uacc4\uc5d0 \ub300\ud55c \ud559\uc220 \uc13c\ud130\uc758 \ud544\uc694\uc131\uc744 \ubc18\uc601\ud558\uc5ec 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 50.55%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \ub3d9\ubc18 \uc9c4\ub2e8(CDx)\uc758 \uaddc\uc81c \uac00\uc18d\ud654\ub294 2031\ub144\uae4c\uc9c0 12.44%\uc758 CAGR\uc744 \uc774\ub04c\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc801\uc751\uc99d\ubcc4: \ud3d0\uc554\uc740 PD-L1, KRAS, EGFR \ud504\ub85c\ud30c\uc77c\ub9c1\uc744 \uc758\ubb34\ud654\ud558\ub294 \ud655\ub9bd\ub41c \uac00\uc774\ub4dc\ub77c\uc778 \ub355\ubd84\uc5d0 2025\ub144 \uc2dc\uc7a5 \uaddc\ubaa8\uc758 31.65%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc720\ubc29\uc554\uc740 HER2-low, HER2-ultra-low \ubc0f \uba74\uc5ed \ubc14\uc774\uc624\ub9c8\ucee4\uac00 \uc784\uc0c1 \uc758\uc0ac \uacb0\uc815 \ud2b8\ub9ac\ub97c \ud655\uc7a5\ud568\uc5d0 \ub530\ub77c 12.62%\uc758 CAGR\uc744 \uae30\ub85d\ud560 \uc900\ube44\uac00 \ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc0d8\ud50c \uc720\ud615\ubcc4: \uc870\uc9c1 \uc0dd\uac80\uc740 \uc798 \ud655\ub9bd\ub41c \ud504\ub85c\ud1a0\ucf5c\uacfc \ud48d\ubd80\ud55c \uc870\uc9c1 \ubcd1\ub9ac\ud559\uc801 \ub9e5\ub77d\uc5d0 \ud798\uc785\uc5b4 2025\ub144 \uc2dc\uc7a5\uc758 52.35%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc561\uccb4 \uc0dd\uac80\uc758 12.46% CAGR\uc740 \uc21c\ud658 \uc885\uc591 DNA, \uc5d1\uc18c\uc880 \ubc0f \uba54\ud2f8\ud654 \ubd84\uc11d\uc758 \ubc1c\uc804\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 \uae00\ub85c\ubc8c \ub9e4\ucd9c\uc758 41.90%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc720\ub9ac\ud55c \uc0c1\ud658 \uc815\ucc45, AI \uc870\uae30 \ucc44\ud0dd, \uc885\ud569 \uc554 \uc13c\ud130\uc758 \ubc00\uc9d1\ub41c \ub124\ud2b8\uc6cc\ud06c\ub97c \ud1b5\ud574 \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: \ubcf4\uac74 \uae30\uc220 \ud3c9\uac00(HTA)\uac00 \uad11\ubc94\uc704\ud55c \ucd9c\uc2dc \uc804\uc5d0 \uc784\uc0c1\uc801 \uc774\uc810\uc744 \uac80\uc99d\ud558\uba74\uc11c \uade0\ud615 \uc7a1\ud78c \ubc1c\uc804\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc5ec\ub7ec \uad6d\uac00\uc758 \uc2b9\uc778 \uc808\ucc28\uac00 \uc9c4\ub2e8 \uae30\uae30 \ucd9c\uc2dc\ub97c \uc9c0\uc5f0\uc2dc\ud0ac \uc218 \uc788\uc9c0\ub9cc, \uac04\uc18c\ud654\ub41c EU IVDR(\uccb4\uc678 \uc9c4\ub2e8 \uc758\ub8cc\uae30\uae30 \uaddc\uc815) \uc900\uc218 \uacbd\ub85c\ub294 2026\ub144 \uc774\ud6c4 \uc2dc\uc7a5 \ucd9c\uc2dc \uae30\uac04\uc744 \ub2e8\ucd95\ud560 \uac83\uc73c\ub85c \uae30\ub300\ub429\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: \uc911\uad6d\uc774 \uad6d\uac00 \uc554 \uac80\uc9c4 \ud504\ub85c\uadf8\ub7a8\uc744 \ubc30\ud3ec\ud558\uace0 \uc77c\ubcf8\uc774 \uc720\uc804\uccb4 \uac80\uc0ac\ub97c \ubcf4\uc870\ud558\uba70, \uc778\ub3c4\uc640 \ud55c\uad6d\uc758 \uc815\ubc00 \uc758\ud559 \ud5c8\ube0c\uac00 \uc218\uc694\ub97c \ub354\uc6b1 \uc790\uadf9\ud558\uba74\uc11c 12.55%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\uc744 \ubcf4\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8: \uac78\ud504 \uad6d\uac00\ub4e4\uc774 \uc6b0\uc218 \uc554 \uc13c\ud130\uc5d0 \ud22c\uc790\ud558\uace0 \ub2e4\uc911 \ud50c\ub7ab\ud3fc\uc744 \uc870\ub2ec\ud558\uba74\uc11c \uc810\uc9c4\uc801\uc778 \ucc44\ud0dd\uc774 \uc774\ub8e8\uc5b4\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub0a8\ubbf8\ub294 \ube0c\ub77c\uc9c8\uc758 \uacf5\uacf5-\ubbfc\uac04 \uc554 \ud30c\ud2b8\ub108\uc2ed\uacfc \uc544\ub974\ud5e8\ud2f0\ub098\uc758 \uc720\uc804\uccb4 \uac80\uc0ac \uad6d\uac00 \uac00\uc774\ub4dc\ub77c\uc778 \ud3ec\ud568\uc5d0 \ud798\uc785\uc5b4 \uafb8\uc900\ud55c \ubc1c\uc804\uc744 \uae30\ub85d\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc11d \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\ub85c \ud1b5\ud569\ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4. Thermo Fisher Scientific\uc758 Olink \uc778\uc218(31\uc5b5 \ub2ec\ub7ec)\ub294 \uace0\ucc98\ub9ac\ub7c9 \ub2e8\ubc31\uc9c8\uccb4\ud559\uc744 \uae30\uc874 NGS \ud0a4\ud2b8\uc640 \ud1b5\ud569\ud558\uc5ec \uc5d4\ub4dc\ud22c\uc5d4\ub4dc \uc11c\ube44\uc2a4 \uc5ed\ub7c9\uc744 \uac15\ud654\ud588\uc2b5\ub2c8\ub2e4. Veracyte\uc758 C2i Genomics \uc778\uc218(9,500\ub9cc \ub2ec\ub7ec)\ub294 \ucd5c\uc18c \uc794\uc874 \uc9c8\ud658(Minimal Residual Disease, MRD) \ubaa8\ub2c8\ud130\ub9c1\uc73c\ub85c \ud655\uc7a5\ub429\ub2c8\ub2e4.<\/p>\n<p>\uae30\uc220 \ucc28\ubcc4\ud654\ub294 AI \uae30\ubc18 \ub2e4\uc911 \uc774\ubbf8\uc9d5 \ubc0f \ub370\uc774\ud130 \ud1b5\ud569\uc5d0 \uc911\uc810\uc744 \ub461\ub2c8\ub2e4. Owkin\uc758 TLS Detect\ub294 \ub9bc\ud504\uad6c \uc0bc\ucc28 \uad6c\uc870(Tertiary Lymphoid Structures, TLS) \uac10\uc9c0\uc5d0\uc11c 97%\uc758 \ubbfc\uac10\ub3c4\ub97c \ub2ec\uc131\ud558\uc5ec \uacf5\uac04 AI \ubd84\uc11d\uc758 \uae30\uc900\uc744 \uc81c\uc2dc\ud569\ub2c8\ub2e4. Guardant Health\uc640 ConcertAI\uc758 \ud30c\ud2b8\ub108\uc2ed\uc740 \ubc29\ub300\ud55c \uc804\uc790 \uc758\ub8cc \uae30\ub85d\uacfc \ubd84\uc790 \ub370\uc774\ud130\ub97c \ud1b5\ud569\ud558\uc5ec \uc2e4\uc81c \uc99d\uac70 \ubc0f \uc9c0\ubd88\uc790 \uc218\uc6a9\ub3c4\ub97c \ub192\uc785\ub2c8\ub2e4.<\/p>\n<p>\ud654\uc774\ud2b8 \uc2a4\ud398\uc774\uc2a4 \ud601\uc2e0\uc740 \ubd84\uc0b0\ub41c \uc6cc\ud06c\ud50c\ub85c\uc6b0\ub97c \ubaa9\ud45c\ub85c \ud569\ub2c8\ub2e4. Mursla Bio\uc640 \uac19\uc740 \uae30\uc5c5\uc740 \uc7a5\uae30 \ud2b9\uc774\uc801 \uc2dc\uadf8\ub2c8\ucc98\uc5d0 \ub9de\ucdb0\uc9c4 \uc138\ud3ec\uc678 \uc18c\ud3ec \uae30\ubc18 \ubd84\uc11d\uc5d0 \uc911\uc810\uc744 \ub450\uc5b4 \uc911\uc559 \uc2e4\ud5d8\uc2e4 \uc11c\ube44\uc2a4\ub97c \ubcf4\uc644\ud569\ub2c8\ub2e4. \uc911\uacac \uae30\uc5c5\ub4e4\uc740 ISO \uc778\uc99d \uc81c\uc870 \ubc0f \uc9c0\uc5ed \uc720\ud1b5\uc744 \ud65c\uc6a9\ud558\uc5ec \uc885\ud569 \uba74\uc5ed \ud328\ub110\uc744 \ucc44\ud0dd\ud558\ub294 \ubcd1\uc6d0\uc5d0 \uc11c\ube44\uc2a4\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc784\uc0c1\uc801 \uc720\uc6a9\uc131\uc774 \ud655\ub300\ub428\uc5d0 \ub530\ub77c, \uc2dc\uc7a5 \uc131\uacf5\uc740 \ud1b5\ud569\ub418\uace0 \uaddc\uc81c\uc5d0 \uc801\ud569\ud558\uba70 \uc784\uc0c1\uc758 \uce5c\ud654\uc801\uc778 \uc194\ub8e8\uc158\uc744 \uc81c\uacf5\ud558\ub294 \uae30\uc5c5\uc5d0\uac8c \uc720\ub9ac\ud560 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc0b0\uc5c5 \ub9ac\ub354:<\/p>\n<p>*   Agilent Technologies, Inc.<br \/>\n*   Thermo Fisher Scientific<br \/>\n*   Illumina, Inc.<br \/>\n*   PerkinElmer, Inc.<br \/>\n*   Crown Bioscience<\/p>\n<p>\ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5:<\/p>\n<p>*   2025\ub144 7\uc6d4: FDA\ub294 EGFR \uc5d1\uc190 20 \uc0bd\uc785\uc774 \uc788\ub294 \uc804\uc774\uc131 \ube44\uc18c\uc138\ud3ec\ud3d0\uc554(NSCLC)\uc5d0 \ub300\ud55c \uc120\ubcf4\uc800\ud2f0\ub2d9(Zegfrovy)\uc758 \uac00\uc18d \uc2b9\uc778\uc744 \ubd80\uc5ec\ud588\uc73c\uba70, Oncomine Dx Express Test\uac00 \ub3d9\ubc18 \uc9c4\ub2e8\uc73c\ub85c \uc2b9\uc778\ub418\uc5c8\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 5\uc6d4: Roche\ub294 \ube44\ud3b8\ud3c9 \ube44\uc18c\uc138\ud3ec\ud3d0\uc554\uc5d0\uc11c MET \ub2e8\ubc31\uc9c8\uc5d0 \ub300\ud55c \ucd5c\ucd08\uc758 \ub3d9\ubc18 \uc9c4\ub2e8\uc73c\ub85c VENTANA MET (SP44) RxDx \ubd84\uc11d\uc5d0 \ub300\ud55c FDA \uc2b9\uc778\uc744 \ud68d\ub4dd\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 4\uc6d4: Ventana TROP2 (EPR20043) RxDx \ubd84\uc11d\uc740 \ube44\uc18c\uc138\ud3ec\ud3d0\uc554\uc5d0\uc11c \ub2e4\ud1a0\ud3ec\ud0c0\ub9d9 \ub370\ub8e9\uc2a4\ud14c\uce78(datopotamab deruxtecan) \uc120\ud0dd\uc744 \uc704\ud55c \ud601\uc2e0 \uc758\ub8cc\uae30\uae30 \uc9c0\uc815\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 4\uc6d4: Guardant Health\ub294 742\uac1c\uc758 DNA \ubc0f 367\uac1c\uc758 RNA \uc720\uc804\uc790\ub97c \ubd84\uc11d\ud558\uba74\uc11c \ub354 \uc801\uc740 \uc2ac\ub77c\uc774\ub4dc\ub97c \uc0ac\uc6a9\ud558\ub294 Guardant360 Tissue \ub2e4\uc911 \uc624\ubbf9\uc2a4 \ud504\ub85c\ud30c\uc77c\ub9c1 \ud14c\uc2a4\ud2b8\ub97c \ucd9c\uc2dc\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>(\ucc38\uace0: \ubcf8 \ubcf4\uace0\uc11c\uc758 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc608\uce21 \uc218\uce58\ub294 Mordor Intelligence\uc758 \ub3c5\uc810\uc801\uc778 \ucd94\uc815 \ud504\ub808\uc784\uc6cc\ud06c\ub97c \uc0ac\uc6a9\ud558\uc5ec \uc0dd\uc131\ub418\uc5c8\uc73c\uba70, 2026\ub144 1\uc6d4 \ud604\uc7ac \uc0ac\uc6a9 \uac00\ub2a5\ud55c \ucd5c\uc2e0 \ub370\uc774\ud130 \ubc0f \ud1b5\ucc30\ub825\uc73c\ub85c \uc5c5\ub370\uc774\ud2b8\ub418\uc5c8\uc2b5\ub2c8\ub2e4.)\uc774\ub7ec\ud55c \ucd5c\uc2e0 \ub3d9\ud5a5\uacfc \ub370\uc774\ud130\ub294 \ub3d9\ubc18 \uc9c4\ub2e8 \uc2dc\uc7a5\uc758 \uc9c0\uc18d\uc801\uc778 \uc131\uc7a5\uacfc \ud601\uc2e0\uc744 \uba85\ud655\ud788 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \ub2e4\uc74c \uc139\uc158\uc5d0\uc11c\ub294 \uc774\ub7ec\ud55c \uc2dc\uc7a5\uc758 \uc8fc\uc694 \ub3d9\uc778, \uc81c\uc57d \uc694\uc778 \ubc0f \ubbf8\ub798 \uae30\ud68c\ub97c \uc2ec\uce35\uc801\uc73c\ub85c \ubd84\uc11d\ud560 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>\uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc11d(Immuno Oncology Assays) \uc2dc\uc7a5 \ubcf4\uace0\uc11c\ub294 \uba74\uc5ed \ubc0f \uc885\uc591 \uc138\ud3ec \uc5ed\ud559\uc744 \uc2e4\uc2dc\uac04\uc73c\ub85c \uc790\ub3d9 \uce21\uc815\ud558\ub294 \ucc28\uc138\ub300 \uc2dc\ud000\uc2f1(NGS) \uc560\ud50c\ub9ac\ucf00\uc774\uc158\uc5d0 \ub300\ud55c \uc2ec\uce35 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc774\ub294 \uc554\uc5d0 \ub300\ud55c \uba74\uc5ed \ubc18\uc751\uc744 \uc720\ub3c4\ud558\ub294 \uc0dd\ubb3c\ud559\uc801 \uacfc\uc815\uc744 \ubd84\uc11d\ud558\uace0, \uc99d\uc2dd, \ud65c\uc131\ud654, \uc774\ub3d9 \ubc0f \uba74\uc5ed \uc138\ud3ec \uc0ac\uba78\uacfc \uac19\uc740 \ud575\uc2ec \uc774\ubca4\ud2b8\ub97c \uae30\uc874 \uc138\ud3ec\ub97c \ubc29\ud574\ud558\uc9c0 \uc54a\uace0 \uc9c0\uc18d\uc801\uc73c\ub85c \uac80\uc0ac \ubc0f \ubd84\uc11d\ud558\ub294 \ub370 \ub3c4\uc6c0\uc744 \uc90d\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\uc5d0 \ub530\ub974\uba74, \uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc11d \uc2dc\uc7a5\uc740 2031\ub144\uae4c\uc9c0 118\uc5b5 7\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc5d0 \ub3c4\ub2ec\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR)\uc740 11.88%\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 \uc804 \uc138\uacc4 \uc554 \ubc1c\ubcd1\ub960\uc758 \uc9c0\uc18d\uc801\uc778 \uc99d\uac00, \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c(Immune-checkpoint Inhibitors)\uc758 \ucc44\ud0dd \ud655\ub300, \ub3d9\ubc18\uc9c4\ub2e8(Companion Dx) \ubd84\uc11d(PD-1\/PD-L1, TMB)\uc758 \uaddc\uc81c \uc2b9\uc778 \uc99d\uac00\uac00 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \uc81c\uc57d-\uc9c4\ub2e8 \uacf5\ub3d9 \uac1c\ubc1c \ud30c\ud2b8\ub108\uc2ed\uc744 \ud1b5\ud55c \ud14c\uc2a4\ud2b8 \uba54\ub274 \uac00\uc18d\ud654, AI \uae30\ubc18 \ub2e4\uc911 \uacf5\uac04 \ud504\ub85c\ud30c\uc77c\ub9c1(Multiplex Spatial Profiling)\uc744 \ud1b5\ud55c \ubc14\uc774\uc624\ub9c8\ucee4 \ubc1c\uacac \ucd09\uc9c4, \uc9c0\uc5ed\uc0ac\ud68c \uc885\uc591\ud559 \ubd84\uc57c\uc5d0\uc11c\uc758 \ubd84\uc0b0\ud615 \uc561\uccb4 \uc0dd\uac80(Liquid Biopsy) \ud14c\uc2a4\ud2b8 \ud655\uc0b0 \ub4f1\uc774 \uae0d\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\uce58\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \ub192\uc740 \ubd84\uc11d \ube44\uc6a9\uacfc \ubcf5\uc7a1\ud55c \ubcf4\ud5d8 \uc0c1\ud658 \uc808\ucc28, \uc5c4\uaca9\ud55c \ub2e4\uc911 \uad00\ud560\uad8c \uaddc\uc81c \uac80\uc99d \uc694\uad6c\uc0ac\ud56d, \uc798 \uc8fc\uc11d\ud654\ub41c \uc77c\uce58 \uc885\uc591\/\uc815\uc0c1 \ubc14\uc774\uc624\ubc45\ud06c\uc758 \ubd80\uc871, \ub2e4\uc911 \ubd84\uc11d \ud504\ub85c\ud1a0\ucf5c\uc758 \uae00\ub85c\ubc8c \ud45c\uc900\ud654 \ubbf8\ube44 \ub4f1\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc81c\ud488\ubcc4\ub85c\ub294 \uc2dc\uc57d \ubc0f \ud56d\uccb4(Reagents &#038; Antibodies) \ubd80\ubb38\uc774 \uba74\uc5ed \ud504\ub85c\ud30c\uc77c\ub9c1 \uc6cc\ud06c\ud50c\ub85c\uc6b0\uc758 \uc18c\ubaa8\ud488 \uc9d1\uc57d\uc801 \ud2b9\uc131\uc744 \ubc18\uc601\ud558\uc5ec \uc804 \uc138\uacc4 \ub9e4\ucd9c\uc758 39.65%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uae30\uc220\ubcc4\ub85c\ub294 \ub2e8\uc77c \uc138\ud3ec \ubc0f \ub9e5\ub77d\uc774 \ud48d\ubd80\ud55c \ubd84\uc11d \ud50c\ub7ab\ud3fc\uc758 \ucc44\ud0dd\uc774 \uc99d\uac00\ud568\uc5d0 \ub530\ub77c \ub2e4\uc911 \uacf5\uac04 \ud504\ub85c\ud30c\uc77c\ub9c1(Multiplex Spatial Profiling)\uc774 \uc5f0\ud3c9\uade0 12.48%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \ubd80\ubb38\uc73c\ub85c \ub098\ud0c0\ub0ac\uc2b5\ub2c8\ub2e4. \ubd84\uc11d \uc720\ud615\ubcc4\ub85c\ub294 MET, KRAS G12C, TROP2\ub97c \ud45c\uc801\uc73c\ub85c \ud558\ub294 \ubd84\uc11d\ubc95\uc5d0 \ub300\ud55c \ucd5c\uadfc FDA \uc2b9\uc778\uc774 \ub2e4\uc911 \ub9e4\uac1c\ubcc0\uc218 \ud14c\uc2a4\ud2b8\ub97c \uac80\uc99d\ud558\uba74\uc11c \ub3d9\ubc18\uc9c4\ub2e8(Companion Diagnostic, CDx) \ubd80\ubb38\uc774 \uc5f0\ud3c9\uade0 12.44%\uc758 \uc131\uc7a5\ub960\ub85c \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc0d8\ud50c \uc720\ud615\ubcc4\ub85c\ub294 \uc21c\ud658 \uc885\uc591 DNA\uc758 \ube44\uce68\uc2b5\uc801 \ubaa8\ub2c8\ud130\ub9c1\uc5d0 \uc0ac\uc6a9\ub418\ub294 \uc561\uccb4 \uc0dd\uac80(Liquid Biopsy) \ud14c\uc2a4\ud2b8\uac00 \uc870\uc9c1 \uae30\ubc18 \ubd84\uc11d\uc744 \ubcf4\uc644\ud558\uba70 \uc5f0\ud3c9\uade0 12.46%\uc758 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc801\uc751\uc99d\ubcc4\ub85c\ub294 \ud3d0\uc554, \ub300\uc7a5\uc554, \ud751\uc0c9\uc885, \uc720\ubc29\uc554 \ubc0f \uae30\ud0c0 \uc554\uc885\uc774 \uc8fc\uc694 \ubd84\uc11d \ub300\uc0c1\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\ubcc4\ub85c\ub294 \uc554 \ubc1c\ubcd1\ub960 \uc99d\uac00, \uc120\ubcc4 \ud504\ub85c\uadf8\ub7a8 \ud655\ub300, \uaddc\uc81c \uacbd\ub85c \uac04\uc18c\ud654\uc5d0 \ud798\uc785\uc5b4 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 12.55%\ub85c \uac00\uc7a5 \ub192\uc740 \uc131\uc7a5 \uc7a0\uc7ac\ub825\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd\uc5d0\ub294 Agilent Technologies, Thermo Fisher Scientific, Illumina, Roche, Qiagen \ub4f1 \uc8fc\uc694 \uae00\ub85c\ubc8c \uae30\uc5c5\ub4e4\uc774 \ud3ec\ud568\ub418\uc5b4 \uc788\uc73c\uba70, \uc774\ub4e4\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4 \ubc0f \uc804\ub7b5\uc801 \uac1c\ubc1c \uc0ac\ud56d\uc774 \ubd84\uc11d\ub429\ub2c8\ub2e4. \ubcf8 \ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd, \ud2b9\ud788 \uc2dc\uc7a5\uc758 \ubbf8\ucda9\uc871 \uc218\uc694(Unmet-Need) \ud3c9\uac00\ub97c \ud1b5\ud574 \uba74\uc5ed\ud56d\uc554\uc81c \ubd84\uc11d \uc2dc\uc7a5\uc758 \uc804\ubc18\uc801\uc778 \ubc1c\uc804 \ubc29\ud5a5\uc744 \uc81c\uc2dc\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-39215","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/39215"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=39215"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/39215\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=39215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=39215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=39215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}